NN

NNAMDI NWACHUKWU

Biotech | Asset Valuation | Venture Capital | AI/ML/RWD(E) in Pharmaceutical Development

Washington, District of Columbia

Investor
VC

Invests in

Stages:

Seed
Pre-seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Quality Reviews
Privacy Policies
Building Management Systems
U.S. Health Insurance Portability and Accountability Act (HIPAA)
Industry standards
Quality Risk Management
Value Creation
Venture Capital
Performance Engineering
Concept to Launch
Software Development
Technical Leadership
Regulatory Requirements
Computer Science
Stability Studies
Immunology
Oncology
Research Methods
Market Access
Social Influence

Education

Work Experience

RRD International, LLC

2019

  • Senior Vice President, Quality & Chief Information Officer

    2019

George Mason University - Volgenau School of Engineering

2020

  • Advisory Board Member

    2020

  • Adjunct Lecturer

    2020

    Bioengineering (Vaccine Manufacturing & Pharmaceutical Engineering)

Oxford Angel Fund

2021 - 2024

  • Venture Associate - Life Sciences Investments

    2021 - 2024

Community of Hope

2020 - 2022

  • Advisory Board Member and Vice Chair of the Quality Management Committee

    2020 - 2022

Altimmune, Inc.

2017 - 2019

  • Head, Regulatory Affairs and Quality Operations

    2017 - 2019

United States Department of Defense

2016 - 2017

  • Head, Regulatory Portfolio Advisor

    2016 - 2017

PATH - Center for Vaccine Innovation & Access

2014 - 2016

  • Regulatory CMC Manager / Health Economist

    2014 - 2016

Amgen

2013 - 2014

  • Senior Regulatory Management Consultant

    2013 - 2014

Fresenius Medical Care

2012 - 2013

  • Regulatory Affairs Engineer

    2012 - 2013

Genzyme

2010 - 2012

  • Quality Systems Engineer

    2010 - 2012